Completion of preclinical data package for RAD 402
Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402 Download the PDF here. This post appeared...
Read moreRadiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402 Download the PDF here. This post appeared...
Read moreLundin Mining (TSX:LUN,OTC Pink:LUNMF) has entered a definitive agreement to sell its Neves-Corvo operation in Portugal and Zinkgruvan operation in...
Read moreThe Trump administration’s ability to reign in government spending, quash inflation and bolster the economy were the most prevalent topics...
Read moreTikTok in a court filing Monday warned that U.S. small businesses and social media creators would lose $1.3 billion in revenue...
Read morePresident-elect Trump reacted Sunday morning to the news that Syrian dictator Bashar Assad had fled Syria after rebels stormed the...
Read moreA group of unknown gunmen stormed the Iranian embassy in Damascus on Sunday after Islamist rebels took the city and...
Read moreBefore President Biden was inaugurated as the nation’s 46th president, he and his administration put its staunch support of transgender...
Read morePresident-elect Donald Trump’s allies are expected to ramp up criticisms against Republican Iowa Sen. Joni Ernst as she stalls on...
Read morePresident Biden said during a Sunday afternoon press conference that the U.S. will support Syria’s neighboring nations and help bolster...
Read moreThe fall of Syria’s President Bahsar al-Assad is a blow to Russia, terror-monger Iran, and their Hezbollah cronies in Lebanon. But...
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved